Navellier & Associates’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-42,728
Closed -$3.84M 270
2022
Q2
$3.84M Buy
42,728
+1,888
+5% +$195K 0.82% 37
2022
Q1
$4.58M Buy
40,840
+2,371
+6% +$278K 0.78% 40
2021
Q4
$4.65M Sell
38,469
-1,455
-4% -$162K 0.68% 47
2021
Q3
$4.02M Sell
39,924
-607
-1% -$67K 0.61% 56
2021
Q2
$4.73M Buy
40,531
+699
+2% +$83.9K 0.71% 45
2021
Q1
$4.39M Buy
39,832
+1,663
+4% +$181K 0.79% 41
2020
Q4
$3.83M Buy
38,169
+418
+1% +$38.8K 0.69% 53
2020
Q3
$2.95M Buy
+37,751
New +$2.85M 0.64% 52

Other funds holding EMN

Navellier & Associates's EMN Position: Q3 2022 in Review

Navellier & Associates sold out of Eastman Chemical (EMN) in Q3 2022, closing a stake of 42,728 shares — an estimated $3.84M sold.

Navellier & Associates first reported a position in EMN in Q3 2020 and held it in 8 quarters. The position peaked at $4.73M in Q2 2021. 656 funds tracked by Wall St. Rank hold EMN as of Q3 2022.

  • Navellier & Associates reported no remaining Eastman Chemical position as of Q3 2022 after selling out during the quarter.
  • Navellier & Associates sold 42,728 Eastman Chemical shares in Q3 2022, an estimated $3.84M.
  • Navellier & Associates first reported a position in Eastman Chemical in Q3 2020 and held it in 8 quarters.
  • Navellier & Associates's Eastman Chemical position peaked at $4.73M in Q2 2021.
  • 656 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2022.

Based on Navellier & Associates's 13F filing for Q3 2022, filed 9 Nov 2022.